Thiopentone was administered in bolus doses (1.5-3.0 mg/kg) 26 times to 18 neurosurgical patients undergoing craniotomy. Intracranial pressure and blood pressure responses to thiopentone were evaluated and the cerebral perfusion pressure calculated. Thiopentone given 21 times to treat chronic or acutely elevated intracranial pressure significantly reduced the mean pressure from 40 ±1.5 to 22 ±1.4 mm Hg (±SD). During these 21 treatments the cerebral perfusion pressure increased in 15, remained stable in 2 and decreased in 3. With induction of anaesthesia in patients with normal pre-thiopentone pressures, the barbiturate produced no significant alteration in intracranial pressure and the cerebral perfusion pressure remained above 85 mm Hg despite moderate reductions in arterial pressure. Frequently the action of the short-acting barbiturate in reducing intracranial pressure was transient, being limited, presumably, by redistribution of the drug.
Certain anaesthetic agents, and some types of stimulation during operation cause rapid increased intracranial pressure in neurosurgical patients. Elevations of pressure may follow noxious stimuli such as laryngoscopy, intubation, application of a head clamp, skin incision (Shapiro et aL, 1972b) , or follow administration of certain anaesthetic agents (Jennett et al., 1969; Shapiro, Wyte and Harris, 1972) . Spontaneous increases of intracranial pressure have also been reported (Lundberg, 1960) . These elevations may be sufficient to establish gradients of intracranial pressure leading to brain shifts (Fitch and McDowall, 1971) , tissue compression and regional and/or total cerebral blood flow reduction (Zwetnow, 1970) . During anaesthesia, reduction of the inspired concentration of the volatile agent or the administration of an osmotic dehydrating agent may not block or decrease a rapidly increasing intracranial pressure. Hyperventilation can, by decreasing the arterial carbon dioxide tension, often rapidly reduce an elevated pressure. Unfortunately, absolute control of the airway and ventilation is not always possible during anaesthetic induction. Ventricular cerebrospinal fluid removal can also rapidly lower intracranial pressure. However, this method is not always feasible and, when available, the ventricular catheter may become occluded when most needed. It is desirable, therefore, to have an agent that can be injected intravenously in order to obtain control when a sudden rise in intracranial tension occurs.
Thiopentone increases cerebral vascular resistance, decreases cerebral blood flow and the cerebral metabolic rate (Pierce et aL, 1962) . Theoretically these properties might be used to produce a rapid reduction of acute intracranial hypertension caused by cerebrovascular dilatation and increased intracranial Hood volume (Risberg, Lundberg and Ingvar, 1969) . We have evaluated the efficacy of thiopentone treatment for increased intracranial pressure in patients undergoing craniotomy under several types of anaesthetics.
METHODS
Intracranial pressure was continuously monitored in 18 neurosurgical patients before and after the induction of anaesthesia. through an intraventricular cannula or via a 19-gauge scalp-vein needle inserted into the dome of a valveless shunt prosthesis with its distal end occluded. The aetiology of the central nervous system lesion was tumour, subarachnoid haemorrhage, primary hydrocephalus, cerebral contusion, or nonspace-occupying seizure focus.
Arterial blood pressure was measured either with a brachial cuff or through a radial artery catheter. All measurements were performed with the patients supine. In 14 patients tie arterial pressure as well as central venous pressure and end-tidal carbon dioxide concentration were continuously monitored. Pressures are reported as the arithmetic mean of the systolic and diastolic values. Cerebral perfusion pressures were determined by subtraction of the mean intracranial pressure from the mean arterial pressure. A change of more than 2 mm Hg (27 mm HjO) in intracranial pressure or calculated cerebral perfusion pressure was considered significant for the purposes of this report.
Either no medication or atropine 0.3-0.5 mg was given I hour before induction of anaesthesia. The anaesthetic protocols were varied in order to compare a volatile anaesthetic technique with one avoiding the use of halothane. In patients 1 through 9 anaesthesia was induced with thiopentone 1.5-3.0 mg/kg and maintained with halothane, nitrous oxide 3 l./min and oxygen 2 l./min. Patients 10 through 18 were given droperidol 100 /*g/kg followed in 5 minutes by fentanyl 5-10 ^g/kg and tubocurarine 0.35-0.45 mg/kg. This was followed by thiopentone 1.5-3.0 mg/kg and anaesthesia was maintained with nitrous oxide 3 L/min and oxygen 2 l./min. Thiopentone induction data were not available for patients 16 and 18.
Thiopentone was given to treat an increase in intracranial pressure in three situations: (1) for induction of anaesthesia; (2) during a period of rapidly rising pressure; and (3) at an elevated pressure following a rapid rise. For the purpose of this report an increase in intracranial pressure is defined as an intracranial tension gain of 10 mm Hg or more in 60 seconds. A pressure reduction response attributed to thiopentone was required to begin within 60 seconds following a bolus dose of the barbiturate and to cause a decline of more than a 2 mm Hg in intracranial tension. This corresponds with the period of brain thiopentone uptake and time of greatest anaesthetic depth (Price, Dundee and Conner, 1957) . The lowest pressure obtained within 5 minutes of the administration of thiopentone is reported. By this time the brain concentration of thiopentone has decreased by 50% (Price, Dundee and Conner, 1957) . During this observation period the patients were breathing spontaneously prior to anaesthetic induction, or ventilation was controlled at a constant rate. HyperventHation was not initiated during the period of thiopentone evaluation.
An assignment to a response type based on the pre-and post-thiopentone intracranial pressure and cerebral perfusion pressure relationship was performed. Table II contains the definition of these relationships. Utilization of the cerebral pressure permits classification of the intracranial pressure response to a treatment relative to arterial pressure changes. The intracranial pressure was regarded as abnormally high if it exceeded 10 mm Hg, in accordance with Lundberg's (1960) definition. typical example of the response to thiopentone following an abrupt rise in pressure during induction of anaesthesia with droperidol and fentanyL Table I gives the intracranial, arterial and calculated cerebral perfusion pressure values after a rapid intravenous dose of thiopentone. Considering all thiopentone treatments given to patients with abnormally elevated intracranial pressure «10 mm Hg), we found that the pressure declined in 19 of 21 (95%) drug trials (table II) . In 14 of these 21 trials (70%) the calculated cerebral perfusion pressure increased, in some instances from below to over 50 mm Hg. It fell in 15% of treated patients with high intracranial pressure, and all 5 patients with normal preanaesthetic intracranial tension. The perfusion pressure for all treated patients remained at 60 mm Hg or more, except for one patient, in whom it decreased to 35 mm Hg due to arterial hypotension. In patients with normal preoperative intracranial tension (<10 mm Hg), thiopentone had its greatest effect on arterial pressure, and, therefore, on cerebral perfusion pressure, and had little influence on intracranial pressure. These changes were noted during the induction of anaesthesia ( fig. 2 , right lower cluster of arrows, excluding response 3) and represent type HI or IV responses. In no instance did the perfusion pressure fall below 90 mm Hg in these patients. Figure 2 also illustrates the efficacy of thiopentone in reducing an abnormally elevated intracranial pressure existing before anaesthesia (left upper cluster). There were four responses ( fig. 2) leading to a reduction in intracranial pressure with improvement in the perfusion pressure in patients with high intracranial pressure as determined by preoperative measurement.
Thiopentone administered after the onset of an acute intracranial pressure wave caused by intraoperative noxious stimuli or inhalation of halothane quickly diminished the pressure (fig. 3) . The cerebral perfusion pressure was frequently much improved by these treatments.
When thiopentone was given to control elevated intracranial pressure caused by halothane, the duration of the pressure reduction was transient, lasting only from 3 to 7 minutes. Supplementary thiopentone administration could maintain a reduced pressure in this situation, as the inspired concentration of halothane remained constant. The reduction in intracranial pressure achieved with thiopentone after intraoperative mechanical stimulation was longer lasting. Thiopentone never increased the intracranial pressure and there was no abrupt change in the central venous pressure or end-tidal carbon dioxide concentration consequent upon its administration. When intermittently sampled, the arterial carbon dioxide tension ranged between 23 and 32 mm Hg during controlled ventilation. The anaesthetic technique did not appear to alter the intracranial pressure response to thiopentone.
DISCUSSION
Continuous monitoring of intracranial pressure during anaesthesia in neurosurgical patients provides an improved basis for testing therapeutic manoeuvres directed at the maintenance of intracranial homeostasis. Monitoring of the arterial pressure, pulse rate, and respiration is not sufficient to estimate the degree of cerebral circulatory impairment during stressful events, nor does it enable an assessment to be made of the magnitude of intracranial pressure gradients (Heilbrun, Balslev and Boysen, 1972) . Since a generally parallel relationship between cerebral blood flow and cerebral perfusion pressure exists when the perfusion pressure falls below 30 to 50 mm Hg (Heilbrun, Balslev and Boysen, 1972; Zwetnow, 1970) , measurement of the intracranial and arterial pressures can provide information relating to cerebral blood flow. A perfusion pressure below 50 mm Hg may be a warning of present or impending cerebral circulatory impairment, and regional perfusion pressures (about a mass lesion) could be even more dangerously reduced. In 1937 Horsley found minor reductions in lumbar cerebrospinal fluid pressure during barbitone narcosis in 100 normal volunteers. Shortly thereafter this observation was confined by Gurdjian, Webster and Sprunk, (1939) . They also noted that pentobarbitone did not increase spinal fluid pressure when used for sedation in restless head injured patients in the absence of airway obstruction. S^ndefgard (1961) measured intracranial pressure during general anaesthesia in eight neurosurgical patients and observed reductions in intracranial tension during induction of anaesthesia with thiopentone or pcntobarbitone (S0ndergard, 1961) . Hunter (1972) has advocated the use of thiopentone supplemented anaesthesia (continuous intravenous infusion) for neurosurgery. He observed the curvature of the dural surface and reported "excellent" to "good" dural relaxation in a high percentage of his patients. In a preliminary report, we noted the ability of thiopentone to reduce acutely elevated intracranial pressure during operation (Shapiro et aL, 1972a) . Intracranial hypertension caused by ketamine can also be reversed by thiopentone injection (Shapiro, Wyte and Harris, 1972) .
Our present study confirms the ability of thiopentone to reduce chronically (induction responses) and acutely elevated intracranial pressure. Therefore, thiopentone treatment may abort incipient intracranial tissue herniation due to a rapidly expanding intracranial blood volume. Additionally, we found that this short-acting barbiturate frequently improved the cerebral perfusion pressure gradient and could quickly antagonize acute rises of intracranial pressure caused by halothane administration.
Although thiopentone reduces cerebral blood flow in normal persons (Pierce et al., 1962) , it could, potentially, improve regional or total cerebral perfusion in cases of acutely elevated intracranial pressure due to cerebrovasodilatation and augmentation of cerebral blood volume. In this situation, constriction of the cerebral vessels by thiopentone could reduce the intracranial blood volume (a high volume may be stagnant and not represent flow) and intracranial pressure. Then the resistance to flow exerted by the thiopentone-constricted vessels might be less than that due to the high intracranial pressure, and cerebral blood flow could increase. There are no studies confirming this concept.
The transient nature of the reduction in intracranial pressure, obtained with thiopentone, given to control pressure increases caused by halothane and ketamine is probably explained by the rapid reduction in cerebral thiopentone levels after injection of a bolus dose (Price, Dundee and Conner, 1957) , as well as by the continued cerebrovasodilator effects of the anaesthetic agents studied. More prolonged intracranial pressure decreases with thiopentone appear possible if the maximal stimuli increasing the pressure are transient, such as tracheal intubation or incision of the skin. Maintenance of a reduced pressure after treatment of acute intracranial hypertension with thiopentone may possibly be achieved with hyperventilation. The increased cerebrovascular resistance caused by reduced arterial carbon dioxide tension (Reivich, 1964) may supplement further thiopentone treatments. The effect of a combined thiopentonehypocapnic treatment on intracranial pressure was not evaluated in this study, except insofar as the arterial carbon dioxide tension was generally below normal. Finally, reduction of the cerebral metabolic rate by thiopentone may offer some protection against cerebral ischaemia (Nilsson, 1971) caused by high intracranial pressures. The metabolic and cerebrovasoactive properties of thiopentone suggest that it warrants further selective application in the control of intracranial hypertension. It is doubtful whether it is justifiable to discuss the question of changes in the hepatic circulation under the influence of anaesthetics by considering the total hepatic blood flow only, without taking into account the separate proportion of arterial and portal pathways.
My experimental investigations with direct measurement of hepatic blood outflow volume, and also with contrast X-ray angiocinematography, showed that halothane and ether decrease total hepatic blood flow to 60% of the initial values and reduce portal blood flow from 32.8 + 1.6 to 14.1 ±1.8 ml/min/100 g of liver (halothane) or from 37.6 ±4.0 to 13.4 ±1.0 ml/min/100 g (ether). At the same time the hepatic arterial blood flow increased by 30% in the case of halothane (from 7.9 + 0.6 to 10.3 ±1.1 ml/min/100 g), and by 59% with ether (from 8.7 ±0.6 to 13.8 ±1.1 ml/min/100 g).
Thus, the snare of arterial flow in the total liver blood supply increases by more than twice. It is evident that, in conditions of anaesthesia leading to a decrease of hepatic blood flow, oxygenation of hepatic tissue is carried out by a marked arterialization of hepatic sinusoid blood. This reaction apparently contributes to the preservation of hepatocyte viability, but it is carried out to the detriment of other splanchnic system organs, which suffer circulatory hypoxia.
It is interesting to note that ganglionic blockade with pendiomid, reducing arterial pressure from 135 ±4.7 to 108±6.5 mm Hg, considerably increased hepatic artery blood flow (from 8.1±0.4 to 14.6±1.2 ml/min/100 g), and to a lesser degree the portal vein blood flow (from 36.1 ± 1.7 to 42.8±0.8 ml/min/100 g). A more pronounced decrease of arterial pressure leadsj primarily, to a fall in portal venous flow, while a reduction in the arterial blood flow is observed only when arterial pressure is less than 65-70 mm Hg. The question whether it is possible to correct hepatic circulation disturbances during anaesthesia is important in practice. Dr Cooperman writes about only one of die possibilities, the increase in total hepatic blood flow with ganglionic blockade with a background of cyclopropane anaesthesia. We obtained similar results during edier anaesthesia. Also, the administration of oxygen into the lumen of the gastrointestinal tract, in 14 patients during abdominal operations, led to an increase in oxygen saturation of the portal vein blood from 55 ±7.2 to 80 ±6.2% and was accompanied by a decrease in die portocaval gradient from 74 ±12.5 to 38 ±8.7 mm H,O. Experimentally, diis method increased liver oxygen tension and portal blood flow twofold, by decreasing vessel resistance m die liver region of the portal bed.
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